Clinical Trial Update: Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating rivaroxaban to prevent venous thromboembolism in Asian patients with cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rivaroxaban, Cancer-associated Thrombosis | Phase 4 | Status: COMPLETED